Identification of cytochrome P450 2C18 and 2C76 in tree shrews: P450 2C18 effectively oxidizes typical human P450 2C9/2C19 chiral substrates warfarin and omeprazole with less stereoselectivity

被引:3
作者
Uno, Yasuhiro [1 ]
Minami, Yuhki [1 ]
Tsukiyama-Kohara, Kyoko [1 ]
Murayama, Norie [2 ]
Yamazaki, Hiroshi [2 ]
机构
[1] Kagoshima Univ, Joint Fac Vet Med, Kagoshima, Kagoshima 8900065, Japan
[2] Showa Pharmaceut Univ, Machida, Tokyo 1948543, Japan
关键词
cytochromes P450; Liver; Tree shrew; S-WARFARIN; 3A ENZYMES; AMINO-ACID; LIVER; POLYMORPHISMS; DETERMINANTS; TOLBUTAMIDE; METABOLISM; MONKEY; CYP2C;
D O I
10.1016/j.bcp.2023.115990
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochromes P450 (P450s or CYPs), especially the CYP2C family, are important drug-metabolizing enzymes that play major roles in drug metabolism. Tree shrews, a non-rodent primate-like species, are used in various fields of biomedical research, notably hepatitis virus infection; however, its drug-metabolizing enzymes have not been fully investigated. In this study, tree shrew CYP2C18, CYP2C76a, CYP2C76b, and CYP2C76c cDNAs were identified and contained open reading frames of 489 or 490 amino acids with high sequence identities (70-78 %) to human CYP2Cs. Tree shrew CYP2C76a, CYP2C76b, and CYP2C76c showed higher sequence identities (79-80 %) to cynomolgus CYP2C76 and were not orthologous to any human CYP2C. Phylogenetic analysis revealed that tree shrew CYP2C18 and CYP2C76s were closely related to rat CYP2Cs and cynomolgus CYP2C76, respectively. Tree shrew CYP2C genes formed a gene cluster similar to human CYP2C genes. All four tree shrew CYP2C mRNAs showed predominant expressions in liver, among the tissue types examined; expression of CYP2C18 mRNA was also detected in small intestine. In liver, CYP2C18 mRNA was the most abundant among the tree shrew CYP2C mRNAs. In metabolic assays using human CYP2C substrates, all tree shrew CYP2Cs showed metabolic activities toward diclofenac, R,S-omeprazole, paclitaxel, and R,S-warfarin, with the activity of CYP2C18 exceeding that of the other CYP2Cs. Moreover, tree shrew CYP2C76 enzymes metabolized progesterone more efficiently than human, cynomolgus, or marmoset CYP2Cs. Therefore, these novel tree shrew CYP2Cs are expressed abundantly in liver, encode functional enzymes that metabolize human CYP2C substrates, and are likely responsible for drug clearances.
引用
收藏
页数:10
相关论文
共 35 条
[1]   The tree shrews: adjuncts and alternatives to primates as models for biomedical research [J].
Cao, J ;
Yang, EB ;
Su, JJ ;
Li, Y ;
Chow, P .
JOURNAL OF MEDICAL PRIMATOLOGY, 2003, 32 (03) :123-130
[2]   Differential roles of Arg97, Asp293, and Arg108 in enzyme stability and substrate specificity of CYP2C9 [J].
Dickmann, LJ ;
Locuson, CW ;
Jones, JP ;
Rettie, AE .
MOLECULAR PHARMACOLOGY, 2004, 65 (04) :842-850
[3]   Genome of the Chinese tree shrew [J].
Fan, Yu ;
Huang, Zhi-Yong ;
Cao, Chang-Chang ;
Chen, Ce-Shi ;
Chen, Yuan-Xin ;
Fan, Ding-Ding ;
He, Jing ;
Hou, Hao-Long ;
Hu, Li ;
Hu, Xin-Tian ;
Jiang, Xuan-Ting ;
Lai, Ren ;
Lang, Yong-Shan ;
Liang, Bin ;
Liao, Sheng-Guang ;
Mu, Dan ;
Ma, Yuan-Ye ;
Niu, Yu-Yu ;
Sun, Xiao-Qing ;
Xia, Jin-Quan ;
Xiao, Jin ;
Xiong, Zhi-Qiang ;
Xu, Lin ;
Yang, Lan ;
Zhang, Yun ;
Zhao, Wei ;
Zhao, Xu-Dong ;
Zheng, Yong-Tang ;
Zhou, Ju-Min ;
Zhu, Ya-Bing ;
Zhang, Guo-Jie ;
Wang, Jun ;
Yao, Yong-Gang .
NATURE COMMUNICATIONS, 2013, 4
[4]   Clinical relevance of genetic polymorphisms in the human CYP2C subfamily [J].
Goldstein, JA .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) :349-355
[5]  
GOTOH O, 1992, J BIOL CHEM, V267, P83
[6]   Evaluation of 89 Compounds for Identification of Substrates for Cynomolgus Monkey CYP2C76, a New Bupropion/Nifedipine Oxidase [J].
Hosaka, Shinya ;
Murayama, Norie ;
Satsukawa, Masahiro ;
Shimizu, Makiko ;
Uehara, Shotaro ;
Fujino, Hideki ;
Iwasaki, Kazuhide ;
Iwano, Shunsuke ;
Uno, Yasuhiro ;
Yamazaki, Hiroshi .
DRUG METABOLISM AND DISPOSITION, 2015, 43 (01) :27-33
[7]   Monkey liver cytochrome P450 2C19 is involved in R- and S-warfarin 7-hydroxylation [J].
Hosoi, Yoshio ;
Uno, Yasuhiro ;
Murayama, None ;
Fujino, Hideki ;
Shukuya, Mitsunori ;
Iwasaki, Kazuhide ;
Shimizu, Makiko ;
Utoh, Masahiro ;
Yamazaki, Hiroshi .
BIOCHEMICAL PHARMACOLOGY, 2012, 84 (12) :1691-1695
[8]   Identification of residues 99, 220, and 221 of human cytochrome P450 2C19 as key determinants of omeprazole hydroxylase activity [J].
Ibeanu, GC ;
Ghanayem, BI ;
Linko, P ;
Li, LP ;
Pedersen, LG ;
Goldstein, JA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12496-12501
[9]   Influence of cytochrome P450 polymorphisms on drug therapies: Pharmacogenetic, pharmacoepigenetic and clinical aspects [J].
Ingelman-Sundberg, Magnus ;
Sim, Sarah C. ;
Gomez, Alvin ;
Rodriguez-Antona, Cristina .
PHARMACOLOGY & THERAPEUTICS, 2007, 116 (03) :496-526
[10]   High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli [J].
Iwata, H ;
Fujita, K ;
Kushida, H ;
Suzuki, A ;
Konno, Y ;
Nakamura, K ;
Fujino, A ;
Kamataki, T .
BIOCHEMICAL PHARMACOLOGY, 1998, 55 (08) :1315-1325